Meet Your Diabetes Drug Development Needs with TECO Intact Proinsulin
Posted on: November 14, 2024
This is an archived edition of our email newsletter.
It’s Not Just Support. It’s Solutions.
How can blood-based biomarkers enrich your Type 1 or Type 2 Diabetes Study population?
When it comes to measuring pancreatic Beta cell function, go with the pro! Save time and guess work by selectively measuring only intact proinsulin.
Intact Proinsulin is produced by beta-cells (β-cells) in the pancreas and is enzymatically processed into insulin and C-peptide. It is an early indicator of β-cell stress associated with both type 1 and type 2 diabetes (T1D and T2D).
The TECO® Intact Proinsulin ELISA specifically measures intact proinsulin, providing a direct measure of pancreatic β-cell function.
Benefits of the TECO® Intact Proinsulin ELISA:
- Reliable tool for diabetes research and related drug development studies
- Provides valuable information regarding defects in proinsulin processing as an early indicator of β-cell stress
- Measures only intact proinsulin for a cleaner readout – total proinsulin assays measure intact proinsulin as well as des-proinsulin cleavage fragments. Not cross-reactive with intermediates or C-Peptide
- Standardized against WHO reference 09/296, providing transparency
- Assay time less than 3 hours means fast results – no need for overnight incubation
- Consistency provides data that can be compared across sites and studies
Leading Expertise Diabetes Research Assays
For research use only in the U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01200Rev01